TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Standard ART Practice vs. Trophectoderm Biopsy, Whole Chromosome Analysis by Next Generation Sequencing, and Replacement of a Single Euploid Embryo
Brief Summary: We propose to perform a clinical randomized trial to evaluate the effect of blastocyst biopsy and whole chromosome analysis by Next Generation Sequencing (NGS) in comparison to standard Assisted Reproductive Technologies (ART) methods on on implantation rates, miscarriage rates, and pregnancy rates.

This will be three studies into one: a) a comparison of treatment (NGS) and no treatment, b) a non-selection study based on the control group for which we will replace without knowing the ploidy of the embryos, but we will know it later, c) a retrospective study about the use of Mitochondrial DNA as a selection tool.


Options:
A: Arm Label: Endometrial scratch group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: endometrial scratch, Procedure: controlled ovarian hyperstimulation | Arm Label: Assisted hatching group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: assisted hatching, Procedure: controlled ovarian hyperstimulation | Arm Label: ovarian stimulation only group; Type: SHAM_COMPARATOR; Interventions: Procedure: controlled ovarian hyperstimulation | Intervention Type: PROCEDURE; Name: endometrial scratch; Assigned to Arm(s): Endometrial scratch group | Intervention Type: PROCEDURE; Name: assisted hatching; Assigned to Arm(s): Assisted hatching group | Intervention Type: PROCEDURE; Name: controlled ovarian hyperstimulation; Assigned to Arm(s): Assisted hatching group, Endometrial scratch group, ovarian stimulation only group
B: Arm Label: Comprehensive Chromosome Screening; Type: EXPERIMENTAL; Interventions: Other: Comprehensive Chromosome Screening | Arm Label: No Comprehensive Chromosome Screening; Type: PLACEBO_COMPARATOR; Interventions: Other: Morphologically Best | Intervention Type: OTHER; Name: Comprehensive Chromosome Screening; Assigned to Arm(s): Comprehensive Chromosome Screening | Intervention Type: OTHER; Name: Morphologically Best; Assigned to Arm(s): No Comprehensive Chromosome Screening
C: Arm Label: Control - Standard ART treatment; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Test - PGS; Type: EXPERIMENTAL; Interventions: Genetic: Next Generation Sequencing after Blastocyst biopsy | Intervention Type: GENETIC; Name: Next Generation Sequencing after Blastocyst biopsy; Assigned to Arm(s): Test - PGS
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: PIPELLE ENDOMETRIAL SAMPLING | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: PIPELLE ENDOMETRIAL SAMPLING; Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Maternal Supplementation With DHA During Pregnancy and Lactation on the Development of the Term Newborn
Brief Summary: In the present study, we evaluate the effect of the mother suplementación with DHA during the gestation and lactation on diverse aspects of the development of newborn. The effect on the oxidative stress, inflammatory signaling, bone turnover and piscomotor and visual development was studied. Women will in the sixth month of pregnancy, consume a diet balanced during last 3 months of pregnancy and the whole lactation. In addition the women will divide in two groups: one will receive a supplement of docosahexaenoic acid (DHA) to evaluate the effects on the development of the newborn child; whereas another group will receive a placebo. Different samples of blood of the mother and of mother milk will be taken and we will correlating her lipidic profile with the brain development of the newborn child, evaluated by different tests.


Options:
A: Arm Label: DHA supplementation; Type: EXPERIMENTAL; Interventions: Dietary Supplement: DHA Supplementation | Arm Label: Control (milk without DHA); Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Control (milk without DHA) | Intervention Type: DIETARY_SUPPLEMENT; Name: DHA Supplementation; Assigned to Arm(s): DHA supplementation | Intervention Type: DIETARY_SUPPLEMENT; Name: Control (milk without DHA); Assigned to Arm(s): Control (milk without DHA)
B: Arm Label: 200 mg/day DHA; Type: PLACEBO_COMPARATOR; Interventions: Drug: Docosahexaenoic acid - 200mg/day, Other: Placebo | Arm Label: 1000 mg/day DHA; Type: EXPERIMENTAL; Interventions: Drug: Docosahexaenoic acid - 800mg/day, Drug: Docosahexaenoic acid - 200mg/day | Intervention Type: DRUG; Name: Docosahexaenoic acid - 800mg/day; Assigned to Arm(s): 1000 mg/day DHA | Intervention Type: DRUG; Name: Docosahexaenoic acid - 200mg/day; Assigned to Arm(s): 1000 mg/day DHA, 200 mg/day DHA | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): 200 mg/day DHA
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: DHA Supplements | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo Supplements | Intervention Type: DIETARY_SUPPLEMENT; Name: DHA Supplements; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo Supplements; Assigned to Arm(s): 2
D: Arm Label: 1; Type: OTHER; Interventions: Dietary Supplement: omega 3 fatty acids | Arm Label: 2; Type: OTHER; Interventions: Dietary Supplement: vegetable oil | Intervention Type: DIETARY_SUPPLEMENT; Name: omega 3 fatty acids; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: vegetable oil; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To assess the efficacy of an intravenous nonnarcotic pain medication on controlling patient pain.

To assess the effect of an intravenous nonnarcotic pain medication on patient sedation levels in neurocritically ill patients.

To assess the effect of an intravenous nonnarcotic pain medication on common side effects seen in patients taking other intravenous narcotic pain medication in the neurocritical care unit.


Options:
A: Arm Label: Lyrica; Type: EXPERIMENTAL; Interventions: Drug: Pregabalin | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Control | Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): Lyrica | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
B: Arm Label: IV Caldolor (ibuprofen); Type: ACTIVE_COMPARATOR; Interventions: Drug: IV Caldolor | Arm Label: standard treatment group; Type: PLACEBO_COMPARATOR; Interventions: Drug: IV Placebo | Intervention Type: DRUG; Name: IV Caldolor; Assigned to Arm(s): IV Caldolor (ibuprofen) | Intervention Type: DRUG; Name: IV Placebo; Assigned to Arm(s): standard treatment group
C: Arm Label: Intervention group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Intravenous acetaminophen | Arm Label: Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo for IV acetaminophen | Intervention Type: DRUG; Name: Intravenous acetaminophen; Assigned to Arm(s): Intervention group | Intervention Type: DRUG; Name: Placebo for IV acetaminophen; Assigned to Arm(s): Placebo Group
D: Arm Label: Morphine 1 mg; Type: EXPERIMENTAL; Interventions: Drug: Morphine | Arm Label: Morphine 0.5; Type: EXPERIMENTAL; Interventions: Drug: Morphine | Arm Label: Dexketoprofen & Placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexketoprofen, Drug: Placebo | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine 0.5, Morphine 1 mg | Intervention Type: DRUG; Name: Dexketoprofen; Assigned to Arm(s): Dexketoprofen & Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Dexketoprofen & Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 24 Month, Multicenter, Randomized, Open-label Safety and Efficacy Study of Concentration-controlled Everolimus With Reduced Calcineurin Inhibitor vs Mycophenolate With Standard Calcineurin Inhibitor in de Novo Renal Transplantation
Brief Summary: This is a 2-year, randomized, multicenter, open-label, 2-arm study evaluating the graft function of everolimus and reduced CNI versus MPA and standard CNI in adult de novo renal transplant recipients.


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Tacrolimus/Sirolimus | Arm Label: B; Type: EXPERIMENTAL; Interventions: Drug: Tacrolimus/MMF | Arm Label: C; Type: EXPERIMENTAL; Interventions: Drug: Neoral/Sirolimus | Intervention Type: DRUG; Name: Tacrolimus/Sirolimus; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Tacrolimus/MMF; Assigned to Arm(s): B | Intervention Type: DRUG; Name: Neoral/Sirolimus; Assigned to Arm(s): C
B: Arm Label: 1: Myfortic; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mycophenolate Sodium Delayed Release Tablets | Arm Label: 2. Cellcept; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mycophenolate Mofetil | Intervention Type: DRUG; Name: Mycophenolate Sodium Delayed Release Tablets; Assigned to Arm(s): 1: Myfortic | Intervention Type: DRUG; Name: Mycophenolate Mofetil; Assigned to Arm(s): 2. Cellcept
C: Arm Label: EVR+rCNI; Type: EXPERIMENTAL; Interventions: Biological: Induction therapy, Drug: Corticosteroids, Drug: EVR+rCNI | Arm Label: MPA+sCNI; Type: ACTIVE_COMPARATOR; Interventions: Biological: Induction therapy, Drug: Corticosteroids, Drug: MPA+sCNI | Intervention Type: BIOLOGICAL; Name: Induction therapy; Assigned to Arm(s): EVR+rCNI, MPA+sCNI | Intervention Type: DRUG; Name: Corticosteroids; Assigned to Arm(s): EVR+rCNI, MPA+sCNI | Intervention Type: DRUG; Name: EVR+rCNI; Assigned to Arm(s): EVR+rCNI | Intervention Type: DRUG; Name: MPA+sCNI; Assigned to Arm(s): MPA+sCNI
D: Intervention Type: DRUG; Name: sirolimus; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Correlational Study of Pulse Pressure Variation in Various Tidal Volume in Mechanically Ventilated Patients Under General Anaesthesia
Brief Summary: Mesquida, J et al showed there was a significant linear correlation between pulse pressure variations under tidal volume 6 ml/kg and 8 ml/kg in patients after the resuscitation phase of severe sepsis and septic shock. No study revealed the actual relationship between various PPV under different VT. So we hypothesized that there were relationship between various PPV in different tidal volume settings. The objective of this study was to examine the relationship between various PPV.


Options:
A: Arm Label: conventional ventilation, protective ventilation; Type: OTHER; Interventions: Procedure: change ventilation | Intervention Type: PROCEDURE; Name: change ventilation; Assigned to Arm(s): conventional ventilation, protective ventilation
B: Arm Label: change respiratory parameters, volume expanding; Type: EXPERIMENTAL; Interventions: Other: 300 ml Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection infusing in 15 minutes if PPV under VT 8 ml/kg was larger than 13% in the initial investigation | Intervention Type: OTHER; Name: 300 ml Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection infusing in 15 minutes if PPV under VT 8 ml/kg was larger than 13% in the initial investigation; Assigned to Arm(s): change respiratory parameters, volume expanding
C: Arm Label: Low tidal volume; Type: EXPERIMENTAL; Interventions: Other: Ventilation Strategy | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Ventilation Strategy | Intervention Type: OTHER; Name: Ventilation Strategy; Assigned to Arm(s): Low tidal volume, Usual care
D: Intervention Type: OTHER; Name: Abdominal surgery; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Brief Summary: A study of a several doses of a novel treatment for chronic itch compared to placebo for patients whose condition has not responded to other treatments


Options:
A: Arm Label: 0.25 mg VPD-737; Type: EXPERIMENTAL; Interventions: Drug: VPD-737 | Arm Label: 1 mg VPD-737; Type: EXPERIMENTAL; Interventions: Drug: VPD-737 | Arm Label: 5 mg VPD-737; Type: EXPERIMENTAL; Interventions: Drug: VPD-737 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: VPD-737; Assigned to Arm(s): 0.25 mg VPD-737, 1 mg VPD-737, 5 mg VPD-737 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: AN2728 Topical Ointment, 2%; Type: EXPERIMENTAL; Interventions: Drug: AN2728 Topical Ointment, 2% | Arm Label: Matching vehicle control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Matching vehicle control | Intervention Type: DRUG; Name: AN2728 Topical Ointment, 2%; Assigned to Arm(s): AN2728 Topical Ointment, 2% | Intervention Type: DRUG; Name: Matching vehicle control; Assigned to Arm(s): Matching vehicle control
C: Arm Label: AN2728 Topical Ointment, 2%; Type: EXPERIMENTAL; Interventions: Drug: AN2728 Topical Ointment, 2% | Arm Label: Matching vehicle control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Matching vehicle control | Intervention Type: DRUG; Name: AN2728 Topical Ointment, 2%; Assigned to Arm(s): AN2728 Topical Ointment, 2% | Intervention Type: DRUG; Name: Matching vehicle control; Assigned to Arm(s): Matching vehicle control
D: Arm Label: Active Treatment 10 mg BID; Type: EXPERIMENTAL; Interventions: Drug: CP-690,550 | Arm Label: ActiveTreatment 5 mg BID; Type: EXPERIMENTAL; Interventions: Drug: CP-690,550 | Arm Label: Placebo Treatment; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo/CP-690,550 | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): Active Treatment 10 mg BID | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): ActiveTreatment 5 mg BID | Intervention Type: DRUG; Name: Placebo/CP-690,550; Assigned to Arm(s): Placebo Treatment | Intervention Type: DRUG; Name: Placebo/CP-690,550; Assigned to Arm(s): Placebo Treatment

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Web and Mobile Smoking Cessation Interventions
Brief Summary: This study seeks to develop and then perform a controlled efficacy Randomized Controlled Trial assessing tobacco abstinence of a best-practices Web-based PC-delivered smoking cessation intervention (QuitOnline) compared to a Mobile Smartphone-delivered intervention (MobileQuit). Study participants are randomized to one of two conditions: a Web Only intervention and the Web+Mobile intervention. The hypothesis is that the Web+Mobile approach will yield greater efficacy than the Web Only condition.


Options:
A: Arm Label: Web+Mobile; Type: EXPERIMENTAL; Interventions: Behavioral: Web+Mobile | Arm Label: Web Only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Web Only | Intervention Type: BEHAVIORAL; Name: Web+Mobile; Assigned to Arm(s): Web+Mobile | Intervention Type: BEHAVIORAL; Name: Web Only; Assigned to Arm(s): Web Only
B: Arm Label: Crush the Crave Application; Type: EXPERIMENTAL; Interventions: Behavioral: Crush the Crave Application | Arm Label: On the Road to Quitting - Self Help; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: On the Road to Quitting - Self Help | Intervention Type: BEHAVIORAL; Name: Crush the Crave Application; Assigned to Arm(s): Crush the Crave Application | Intervention Type: BEHAVIORAL; Name: On the Road to Quitting - Self Help; Assigned to Arm(s): On the Road to Quitting - Self Help
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Photoaging mobile app promoting poster campaign. | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Photoaging mobile app promoting poster campaign.; Assigned to Arm(s): Intervention
D: Arm Label: MiQuit; Type: EXPERIMENTAL; Interventions: Behavioral: MiQuit | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: MiQuit; Assigned to Arm(s): MiQuit

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Dialectical Behavior Therapy in Patients With Borderline Personality Disorder: a Controlled Trial in Taiwan
Brief Summary: The purpose of this study is to test the hypothesis:

Primary hypothesis: Participants in the dialectical behavior therapy group have greater reductions in the frequency and severity of suicidal and non-suicidal self-injurious behaviors compared to participants in the alternative treatment group.

Secondary Hypotheses: Participants in dialectical behavior therapy group have improved treatment outcomes compared to participants in alternative treatment, including mental health service utilization, symptoms of borderline personality and depression symptoms, suicidal thought and hopelessness, disability, and quality of life.


Options:
A: Arm Label: Dialectical behavior therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical behavior therapy (DBT) | Arm Label: alternative psychotherapy; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Dialectical behavior therapy (DBT) | Intervention Type: BEHAVIORAL; Name: Dialectical behavior therapy (DBT); Assigned to Arm(s): Dialectical behavior therapy, alternative psychotherapy
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive behavioral therapy (CBT) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Brief PTSD treatment | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral therapy (CBT); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Brief PTSD treatment; Assigned to Arm(s): 2
C: Arm Label: Follow up; Type: EXPERIMENTAL; Interventions: Behavioral: Follow up | Arm Label: Usual Treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Follow up; Assigned to Arm(s): Follow up
D: Arm Label: Dialectical Behavior Therapy DBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: DBT | Arm Label: CAMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CAMS | Intervention Type: BEHAVIORAL; Name: DBT; Assigned to Arm(s): Dialectical Behavior Therapy DBT | Intervention Type: BEHAVIORAL; Name: CAMS; Assigned to Arm(s): CAMS

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Dialectical Behavior Therapy in Patients With Borderline Personality Disorder: a Controlled Trial in Taiwan
Brief Summary: The purpose of this study is to test the hypothesis:

Primary hypothesis: Participants in the dialectical behavior therapy group have greater reductions in the frequency and severity of suicidal and non-suicidal self-injurious behaviors compared to participants in the alternative treatment group.

Secondary Hypotheses: Participants in dialectical behavior therapy group have improved treatment outcomes compared to participants in alternative treatment, including mental health service utilization, symptoms of borderline personality and depression symptoms, suicidal thought and hopelessness, disability, and quality of life.


Options:
A: Arm Label: Presence of SUD with BCBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Presence of SUD with TAU; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Absence of SUD with BCBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Absence of SUD with TAU; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): Absence of SUD with BCBT, Presence of SUD with BCBT
B: Arm Label: Dialectical behavior therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical behavior therapy (DBT) | Arm Label: alternative psychotherapy; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Dialectical behavior therapy (DBT) | Intervention Type: BEHAVIORAL; Name: Dialectical behavior therapy (DBT); Assigned to Arm(s): Dialectical behavior therapy, alternative psychotherapy
C: Arm Label: MBT therapy plus treatment as usual; Type: EXPERIMENTAL; Interventions: Other: Mentalization-Based Group Therapy for Adolescents | Arm Label: Treatment as usual alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Mentalization-Based Group Therapy for Adolescents; Assigned to Arm(s): MBT therapy plus treatment as usual
D: Arm Label: PS CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Problem solving cognitive behaviour therapy (PS CBT) | Arm Label: Treatment as Usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Problem solving cognitive behaviour therapy (PS CBT); Assigned to Arm(s): PS CBT

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Dialectical Behavior Therapy in Patients With Borderline Personality Disorder: a Controlled Trial in Taiwan
Brief Summary: The purpose of this study is to test the hypothesis:

Primary hypothesis: Participants in the dialectical behavior therapy group have greater reductions in the frequency and severity of suicidal and non-suicidal self-injurious behaviors compared to participants in the alternative treatment group.

Secondary Hypotheses: Participants in dialectical behavior therapy group have improved treatment outcomes compared to participants in alternative treatment, including mental health service utilization, symptoms of borderline personality and depression symptoms, suicidal thought and hopelessness, disability, and quality of life.


Options:
A: Arm Label: Attachment Based Family Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Attachment Based Family Therapy | Arm Label: Enhanced Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: Attachment Based Family Therapy; Assigned to Arm(s): Attachment Based Family Therapy | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care; Assigned to Arm(s): Enhanced Usual Care
B: Arm Label: Psychoeducational intervention (PEI); Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducational intervention (PEI) | Arm Label: Enhanced Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced treatment as usual (ETAU) | Intervention Type: BEHAVIORAL; Name: Psychoeducational intervention (PEI); Assigned to Arm(s): Psychoeducational intervention (PEI) | Intervention Type: BEHAVIORAL; Name: Enhanced treatment as usual (ETAU); Assigned to Arm(s): Enhanced Treatment as Usual
C: Arm Label: Dialectical behavior therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical behavior therapy (DBT) | Arm Label: alternative psychotherapy; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Dialectical behavior therapy (DBT) | Intervention Type: BEHAVIORAL; Name: Dialectical behavior therapy (DBT); Assigned to Arm(s): Dialectical behavior therapy, alternative psychotherapy
D: Arm Label: Caring Letter Condition (CL); Type: EXPERIMENTAL; Interventions: Behavioral: Caring Letter (email) | Arm Label: Usual Care (UC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Caring Letter (email); Assigned to Arm(s): Caring Letter Condition (CL)

Answer: C